Comment
Helicobacter pylori eradication reduced the risk for ulcers in dyspeptic patients who were about to begin NSAID treatment
Affiliations
- PMID: 12093212
Item in Clipboard
Comment
Helicobacter pylori eradication reduced the risk for ulcers in dyspeptic patients who were about to begin NSAID treatment
ACP J Club.
2002 Jul-Aug.
No abstract available
Comment on
-
Eradication of Helicobacter pylori and risk of peptic ulcers in patients starting long-term treatment with non-steroidal anti-inflammatory drugs: a randomised trial.Lancet. 2002 Jan 5;359(9300):9-13. doi: 10.1016/s0140-6736(02)07272-0. Lancet. 2002. PMID: 11809180 Clinical Trial.
Similar articles
-
Eradication of Helicobacter pylori does not reduce the incidence of gastroduodenal ulcers in patients on long-term NSAID treatment: double-blind, randomized, placebo-controlled trial.Helicobacter. 2007 Oct;12(5):477-85. doi: 10.1111/j.1523-5378.2007.00543.x. Helicobacter. 2007. PMID: 17760715 Clinical Trial.
-
Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.J Rheumatol. 2002 Sep;29(9):1975-80. J Rheumatol. 2002. PMID: 12233895 Clinical Trial.
-
Incidence of complications of peptic ulcers in patients with Helicobacter pylori (Hp) infection and/or NSAID use in the era of Hp eradication.Med Sci Monit. 2002 Aug;8(8):CR554-7. Med Sci Monit. 2002. PMID: 12165741
-
Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.J Physiol Pharmacol. 2006 Sep;57 Suppl 3:67-79. J Physiol Pharmacol. 2006. PMID: 17033106 Review.
-
Interaction of Helicobacter pylori (Hp) and nonsteroidal anti-inflammatory drugs (NSAID) on gastric mucosa and risk of ulcerations.Med Sci Monit. 2002 Sep;8(9):RA197-209. Med Sci Monit. 2002. PMID: 12218957 Review.